Time-dependent histological characterization of amyloid-β induced cholinergic and glial alterations and their modulation by dehydroepiandrosterone sulfate (DHEAS) - Summary - MDSpire
Advertisement
Time-dependent histological characterization of amyloid-β induced cholinergic and glial alterations and their modulation by dehydroepiandrosterone sulfate (DHEAS)
To histologically characterize the in vivo temporal progression of Aβ-induced alterations in cholinergic neurons and glial morphology, and evaluate whether DHEAS protects cholinergic integrity, particularly through glial activation.
Key Findings:
Aβ peptide caused neurotoxic effects on cholinergic neurons and activated glial cells in a time-dependent manner, with specific changes noted at 3, 12, and 33 days.
Microglial activation was observed by day 3, while astrocytic reactivity increased between days 3 and 12.
DHEAS treatment preserved cholinergic fiber density and modulated inflammatory responses of glial cells.
Interpretation:
Aβ toxicity leads to progressive changes in cholinergic and glial cells, while DHEAS shows potential neuroprotective effects that warrant further investigation into its mechanisms.
Limitations:
The study was conducted in a mouse model, which may not fully replicate human AD pathology.
Further research is needed to elucidate the exact mechanisms of DHEAS action and its variability in human responses.
Conclusion:
DHEAS may offer therapeutic benefits in mitigating Aβ-induced neurotoxicity, but further studies are necessary to confirm its efficacy and mechanisms.
